Healthtech Startups

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

5 investors

Remedial Health provides a software platform for pharmaceutical procurement, inventory management, and financing to healthcare providers and small businesses in Africa. The platform streamlines pharmacy operations, enables real-time stock tracking, and offers flexible credit solutions.

5 investors

Remedy Meds offers personalized medical weight loss treatment using compounded GLP-1 medications (semaglutide and tirzepatide) paired with clinician-led care and support delivered directly to patients. The service targets individuals seeking prescription-based weight loss solutions with ongoing medical supervision and community support.

5 investors

Reverie Labs develops cancer treatments designed to cross the blood-brain barrier and treat tumors in the central nervous system.

5 investors

Rex operates veterinary clinics for pets, focusing on dogs, cats, and rabbits, offering general care, dental treatments, and surgeries. It provides an online platform for booking, rescheduling, and canceling appointments, with separate waiting areas for dogs and cats.

5 investors

Rippl delivers evidence-based dementia care through a combination of technology and human support for people living with dementia and their families. The company operates a care model designed to provide personalized support when and where patients and caregivers need it.

5 investors

Risa Labs provides automated prior authorization and revenue-cycle workflows for oncology practices, handling Part B and Part D drug authorizations, eligibility and benefit verification, claims status tracking, and denial management. Its platform integrates with EHRs and payer portals, APIs, and e-fax to execute payer-related administrative tasks with configurable, rules-driven workflows.

5 investors

Rise Science develops RISE, a mobile app that tracks sleep and energy levels while providing personalized recommendations based on sleep debt and circadian rhythm science. The app is designed for consumers seeking to optimize sleep quality and daily energy to improve productivity and overall performance.

5 investors

Rivia Health develops AI-powered patient payment automation software for specialty healthcare practices. The platform streamlines revenue cycle workflows and patient engagement to help providers capture more revenue while improving the patient billing experience.

5 investors

Ryght builds an AI platform for clinical trial site selection and feasibility, using "AI Site Twins" — digital replicas of clinical research sites — to analyze protocols and match sponsors and CROs with high-potential research sites worldwide. It also offers a free search engine (RyghtSites.com) covering 60,000+ global research sites, along with tools for site ranking and automated feasibility outreach.

5 investors

Sana provides health plans and benefits administration services for small businesses, helping employers manage healthcare costs for their teams. The company focuses on delivering affordable coverage and a seamless care experience to members.

5 investors

Sano provides a platform combining genetic testing, patient recruitment, and engagement tools for precision medicine clinical trials. The platform helps research teams enroll participants and manage operations more efficiently in precision medicine studies.

5 investors

Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions. The company uses advanced engineering of natural CRISPR systems to create targeted genetic medicines.

5 investors

Seneca Therapeutics develops oncolytic immunotherapy drug candidates aimed at targeted treatment of solid tumors. The company operates in the biotech and cancer therapeutics space.

5 investors

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.

5 investors

Sequel manufactures re-engineered spiral-design tampons with patented technology for improved absorption and leak prevention. The products are FDA-cleared medical devices designed and founded by female engineers and athletes.

5 investors

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.

5 investors

SFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.

5 investors

Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure. The company operates across Japan and the U.S., combining biotechnology and genetic engineering capabilities in cell therapy development.

5 investors

Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.

5 investors

A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

5 investors

SigTuple builds AI-powered microscopy platforms that combine robotics, microfluidics, and high-resolution imaging to automate microscopic analysis of biological samples such as blood smears for human and veterinary diagnostics. Its products serve pathologists and clinicians in point-of-care settings and clinical laboratories, with a focus on India.

5 investors

Siphox Health develops early diagnostic testing technology to detect and manage chronic diseases at home, delivered as a painless 5-minute test that enables frequent monitoring. The company targets the U.S. healthcare system to reduce the health and economic burden of chronic disease.

5 investors

SmithRx operates a pharmacy benefits management platform that aims to reduce complexity and costs in pharmacy benefits through transparency and technology. The company serves healthcare organizations and patients navigating the U.S. pharmacy benefits system.

5 investors